Pre-made inducible lentiviral particles for expressing human target: RET (alternative name: Dmel_CG14396, CG1061, CG14396, D-ret, DRET, DmHD-59, Dret, HD-59, MEN2, RET, Reto, dRET, dRet, ret), 100% matched CDS region in NCBI ID: NM_020630.
Full sequence verified target is natively expressed under a tetracycline inducible suCMV promoter. A blasticidin-RFP fusion marker under RSV promoter, allows to sort or select transduced cells for long term expression via RFP signal or via blasticidin antibiotic (Dual markers). RFP signal provides a convenient, realtime monitoring the particles performance. Each particles was validated in lot by lot basis and target expression is guaranteed.
See Product Manual for details (.pdf).
Amount: 200ul, at 1 x 107 IFU/ml in DMEM medium containing 10x polybrene.